{"schema_version":"secwatch.filing_event.v1","accession":"0001000228-22-000013","form_type":"8-K","ticker":"HSIC","cik":"0001000228","company_name":"HENRY SCHEIN INC","filed_at":"2022-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.955005+00:00","generated_at":"2026-06-27T07:48:22.876894+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Henry Schein reports record Q4 non-GAAP EPS $1.07, FY sales $12.4B; guides FY22 EPS $4.75–$4.91","bullets":["Q4 sales $3.3B (+5.2% YoY); GAAP EPS $1.05, non-GAAP EPS $1.07 vs. $1.00 last year.","FY 2021 sales $12.4B (+22.6%); GAAP EPS $4.45, non-GAAP EPS $4.52 vs. $2.97 last year.","Global Dental Q4 sales $2.0B (+9.4%); internal growth 6.4% in local currencies.","Global Technology & Value-Added Services Q4 sales $177.2M (+27.8%), internal growth 13.4%.","Board authorized $200M remaining for stock repurchases; bought 2M shares at $75.50/avg in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0001000228-22-000013","json":"https://secwatch.observer/filing/0001000228-22-000013.json","markdown":"https://secwatch.observer/filing/0001000228-22-000013.md","text":"https://secwatch.observer/filing/0001000228-22-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000228/000100022822000013/0001000228-22-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000228/000100022822000013/hsicform8k20220215.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T07:48:22.876894+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}